ARMO Bio Sciences
A biotechnology company that develops immune modulatory biologic therapeutics.
Launch date
Employees
Market cap
-
Enterprise valuation
€1.5b (Public information from May 2018)
Palo Alto California (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
$20.0m | Series A | ||
$30.0m | Series B | ||
$50.0m | Series C | ||
$67.0m | Series C | ||
| N/A | $128m Valuation: $497m | IPO | |
$1.6b Valuation: $1.6b | Acquisition | ||
| Total Funding | €152m | ||
Related Content
Recent News about ARMO Bio Sciences
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.